ArticleRheumatology (Oxford, England)2019

Integrated safety studies of the urate reabsorption inhibitor lesinurad in treatment of gout.

Robert Terkeltaub et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.